VDAC2 primes myeloma cells for BAK-dependent apoptosis and represents a novel therapeutic target.

ABSTRACT:

SUBMITTER: Champion O 

PROVIDER: S-EPMC12075796 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature